Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2004 | 04-2004 | 01-2004 | 10-2003 | 07-2003 | |
| Sales | 224,900 | 153,600 | 136,700 | 47,000 | 152,200 |
| Cost of Goods | 139,100 | 91,000 | 82,800 | 37,500 | 95,200 |
| Gross Profit | 85,800 | 62,600 | 53,900 | 9,500 | 57,000 |
| Operating Expenses | 82,000 | 65,800 | 46,300 | -8,100 | 58,100 |
| Operating Income | 3,900 | -3,200 | 8,400 | 18,100 | -900 |
| Other Income | 200 | 600 | 7,800 | 11,800 | -1,700 |
| Pre-tax Income | 4,100 | -2,600 | 16,200 | 29,900 | -2,600 |
| Income Tax | 300 | 500 | -100 | N/A | N/A |
| Net Income Continuous | 3,800 | -3,100 | 16,300 | 35,000 | -2,600 |
| Net Income Discontinuous | -18,100 | -23,500 | -18,700 | -25,700 | -12,500 |
| Net Income | $-14,300 | $-26,600 | $-2,400 | $9,300 | $-15,100 |
| EPS Basic Total Ops | -0.12 | -0.23 | 0.00 | 0.10 | -0.14 |
| EPS Basic Continuous Ops | 0.03 | -0.03 | 0.14 | 0.28 | 0.00 |
| EPS Basic Discontinuous Ops | -0.15 | -0.20 | -0.14 | -0.18 | -0.14 |
| EPS Diluted Total Ops | -0.12 | -0.23 | 0.00 | 0.10 | -0.14 |
| EPS Diluted Continuous Ops | 0.03 | -0.03 | 0.14 | 0.28 | 0.00 |
| EPS Diluted Discontinuous Ops | -0.15 | -0.20 | -0.14 | -0.18 | -0.14 |
| EBITDA(a) | $32,800 | $5,800 | $-10,600 | $38,000 | $42,200 |